Summary
Purpose: To evaluate the impact of ELIOS combined with cataract surgery on ocular hypotensive medication burden in POAG pts at 24-mo.
Methods: Prospective clinical trial at 20 US sites (NCT04899063). Medication burden was assessed as proportion of patients on ocular hypotensive medications by visit and change from baseline. Ocular adverse events, VF and postoperative BCVA were assessed through the follow-up period.
Results: A total of 289 subjects available for 23mo analysis were included (mean age of 70 years). Mean preoperative number of ocular hypotensive medications was 1.5±0.7. Mean medication burden decreased to 0.3±0.8 at Month 23, corresponding to a mean change of -1.1±0.9. 82% of subjects were medication free at Month 23. At 24 months, VF Mean Deviation remained stable and 98.3% of pts achieved BCVA ≥20/32.
Conclusion: These findings suggest that ELIOS reduced medication burden in patients with mild to moderate open-angle glaucoma undergoing cataract surgery.